首页> 外国专利> Process for reducing insulin resistance in humans in which impaired glucose tolerance or non-insulin dependent diabetes mellitus has not been present in the amount of insulin required daily by a human having diabetes mellitus and insulin resistance in humans for weight improvement and diabetes control in non-insulin dependent diabetes mellitus patients and for long-term prophylaxis and detrimental effects caused by discharge

Process for reducing insulin resistance in humans in which impaired glucose tolerance or non-insulin dependent diabetes mellitus has not been present in the amount of insulin required daily by a human having diabetes mellitus and insulin resistance in humans for weight improvement and diabetes control in non-insulin dependent diabetes mellitus patients and for long-term prophylaxis and detrimental effects caused by discharge

机译：降低人类胰岛素抵抗的方法，其中糖耐量下降或非胰岛素依赖型糖尿病尚不存在于患有糖尿病的人类每天所需的胰岛素量中，并且人类中非胰岛素抵抗者在非肥胖者中用于体重改善和糖尿病控制胰岛素依赖型糖尿病患者以及因出院引起的长期预防和有害作用

页面导航

摘要
著录项
相似文献

摘要

A compound of formula (I) or a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for reducing Insulin resistance in humans in whom Impaired Glucose Tolerance and Non-Insulin Dependent Diabetes Mellitus have not presented.

机译：式（I）的化合物或其药学上可接受的盐，其中R 1和R 2独立地为H或甲基（例如N，N-二甲基-1- [1-（4-氯苯基）环丁基] -3-甲基丁基胺盐酸盐任选地以其一水合物的形式）用于降低未出现葡萄糖耐量降低和非胰岛素依赖型糖尿病的人的胰岛素抵抗。

著录项

公开/公告号BR9711517A

专利类型
公开/公告日1999-08-24

原文格式PDF
申请/专利权人 KNOLL AKTIENGESELLSCHAFT;
展开▼

申请/专利号BR19979711517
发明设计人 ROBERT BRIAN JONES;HELEN BRIAN JONES;CLINFFORD JAMES BAILEY;
展开▼

申请日1997-09-15
分类号A61K31/135;
国家 BR
入库时间 2022-08-22 02:28:04

相似文献

专利
外文文献
中文文献